Bcl-2 related proteins are dramatically induced at the early stage of differentiation in human liver cancer cells by a histone deacetylase inhibitor projecting an anti-apoptotic role during this period

Oncology Reports

Volumn 7, Issue 2, 2000, Pages 285-288

  Wakabayashi, K ^a   Saito, H ^a   Ebinuma, H ^a   Saito, Y ^a   Takagi, T ^a   Nakamura, M ^a   Umezawa, A ^a   Hata, J ^a   Ishii, H ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bcl 2 related proteins; Differentiation; Hepatocellular carcinoma; Histone deacetylase inhibitor

Indexed keywords

BUTYRIC ACID DERIVATIVE; ENZYME INHIBITOR; HISTONE DEACETYLASE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY;

APOPTOSIS; BUTYRATES; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0034146346     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.2.285     Document Type: Article

References (1)

1. Mandal M and Kumar R: Bcl-2 expression regulates sodium butyratc-induced apoptosis in human MCF-7 breast cancer cells. Cell Growth Differ 7: 311-318, 1996.